| Images | Sources | Experiment + Assay | Phenotypes | Human Diseases | ||
|---|---|---|---|---|---|---|
|
Fig. 4 A r1 c2, B
Sun J et al. (2020) |
Xla Wt + spry2 MO
NF 19 (immunohistochemistry) |
|
|||
|
Fig. 1. E r1 c3
Sun J et al. (2020) |
Xla Wt + spry2 MO
NF 33 (immunohistochemistry) |
|
|||
|
Fig. 2 A r1 c2
Sun J et al. (2020) |
Xla Wt + spry2 MO
NF 33 (immunohistochemistry) |
|
|||
|
Fig 3 A r1 c2, C r1 c2
Sun J et al. (2020) |
Xla Wt + spry2 MO
NF 33 (immunohistochemistry) |
|
|||
|
|
Fig. 1. E., F
Sun J et al. (2020) |
Xla Wt + spry2dn
NF 33 (immunohistochemistry) |
|